Inventor · San Francisco, CA, US

Andrew Polson

50Patents
13h-index
54Co-inventors
83Inventor score

Filing activity: Dec 21, 2005 → Feb 22, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8545850B2 Anti-CD79B antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 37 Active
US8088378B2 Anti-CD79B antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 29 Active
US8389697B2 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds Chemistry; Metallurgy 26 Active
US8722857B2 Anti-CD79B antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 21 Active
US8900589B2 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds Chemistry; Metallurgy 19 Active
US9845355B2 Humanized anti-CD79b antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 19 Active
US9896506B2 Anti-CD79B antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 18 Active
US8691531B2 Anti-CD79B antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 18 Active
US8362213B2 Anti-FcRH5 antibodies and immunoconjugates and methods of use Chemistry; Metallurgy 17 Active
US8466260B2 Anti-FcRH5 antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 15 Active
US8617559B2 Anti-FcRH5 antibodies and immunoconjugates and methods of use Chemistry; Metallurgy 14 Active
US7888478B2 Compositions and methods for the treatment of tumor of hematopoietic origin Human Necessities 13 Active
US7858330B2 Compositions and methods for the treatment of tumor of hematopoietic origin Chemistry; Metallurgy 13 Active
US9562099B2 Anti-B7-H4 antibodies and immunoconjugates Chemistry; Metallurgy 12 Active
US9975949B2 Anti-CD79b antibodies and methods of use Chemistry; Metallurgy 11 Active
US9951133B2 Anti-CD33 antibodies and immunoconjugates Physics 10 Active
US7754441B2 Compositions and methods for the treatment of tumor of hematopoietic origin Chemistry; Metallurgy 10 Active
US9695240B2 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds Chemistry; Metallurgy 8 Active
US10059768B2 Anti-B7-H4 antibodies and immunoconjugates Chemistry; Metallurgy 8 Active
US8388973B2 Compositions and methods for the treatment of tumor of hematopoietic origin Human Necessities 7 Active
US9360484B2 Anti-FcRH5 antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 6 Active
US9017951B2 Anti-FcRH5 antibodies and immunoconjugates and methods of use Chemistry; Metallurgy 6 Active
US10150813B2 Anti-B7-H4 antibodies and immunoconjugates Chemistry; Metallurgy 6 Active
US10501545B2 Anti-CLL-1 antibodies and methods of use Chemistry; Metallurgy 4 Active
US10981987B2 Humanized anti-CD79b antibodies and immunoconjugates and methods of use Emerging Cross-Sectional Technologies 3 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.